Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-05-04Cohort Study to Understand Resistance and HIV Eradication (CURE): Observational Studies of Antiretroviral Drug Treatment Success and Failure
-
CLINICAL_TRIALS study record update · 2012-05-02Reducing HIV Transmission Risk Behavior: a Trial of a Two Session Risk-Reduction Intervention With HIV-Positive Men Who Have Sex With Men
-
CLINICAL_TRIALS study record update · 2012-04-30Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma
-
CLINICAL_TRIALS study record update · 2012-04-30A Phase I Pilot Study of the Safety and Efficacy of Interferon Alfa-2b (IFN Alfa-2b) in Combination With Nucleoside Analog Therapy in Patients With Combined Hepatitis C (HCV) and Advanced Human Immunodeficiency Virus (HIV) Infections
-
CLINICAL_TRIALS study record update · 2012-04-27Randomized, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-707035 in HIV-1 Infected Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-04-27A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects.
-
CLINICAL_TRIALS study record update · 2012-04-25A Phase I Placebo-controlled, Double-blinded (in Terms of Vaccine or Placebo), Randomized Dose-escalation Trial to Evaluate the Safety and Immunogenicity of Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers. (IAVI B001)
-
CLINICAL_TRIALS study record update · 2012-04-25A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2012-04-24A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
-
CLINICAL_TRIALS study record update · 2012-04-18HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
-
CLINICAL_TRIALS study record update · 2012-04-17Comparison Study of Liposomal Doxorubicin With or Without Bleomycin and Vincristine for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma
-
CLINICAL_TRIALS study record update · 2012-04-13Affect Management Intervention for Early Adolescents With Mental Health Problems
-
CLINICAL_TRIALS study record update · 2012-04-12An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy
-
CLINICAL_TRIALS study record update · 2012-04-12A 3 Arm, Prospective Study to Compare the Effect of 6 Weeks Exposure to the Combination of Lopinavir (LPVr)/Combivir® (AZT/3TC) Versus Lopinavir Alone or Combivir® Alone in HIV-negative Healthy Subjects on the Development of Abnormalities of Lipid and Glucose Metabolism
-
CLINICAL_TRIALS study record update · 2012-04-10Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
-
CLINICAL_TRIALS study record update · 2012-04-09Prospective Randomized Placebo Controlled Trial of Omega-3 Fatty Acids in HIV Infected Subjects to Modulate Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2012-04-05Study of Genetic Polymorphisms of CYP 3A and MDR-1 Genes in Thai HIV-1 Infected Patients on Saquinavir/Ritonavir
-
CLINICAL_TRIALS study record update · 2012-04-05Pharmacokinetics of and Rate of HIV-1 RNA Decline in ARV-naive HIV-1 Infected Patients Treated With Low- or Standard-dose Saquinavir HGC (Invirase®) and Lopinavir/Ritonavir (Kaletra®
-
CLINICAL_TRIALS study record update · 2012-04-05Pharmacokinetics of Low Dose Ritonavir in Thai Patients on a Saquinavir 1500 mg Based HAART Regimen
-
CLINICAL_TRIALS study record update · 2012-04-05Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques With Popular Opinion Leader (ADAPT-POL)
-
CLINICAL_TRIALS study record update · 2012-04-02Botswana Pediatric Respiratory Disease and Bloodstream Infection
-
CLINICAL_TRIALS study record update · 2012-03-29Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum
-
CLINICAL_TRIALS study record update · 2012-03-29Impact of Peer Health Workers and Mobile Phones on HIV Care
-
CLINICAL_TRIALS study record update · 2012-03-28Pharmacotherapy for HIV Infected Patients With Alcohol Problems
-
CLINICAL_TRIALS study record update · 2012-03-26Randomized, Open Label Study Evaluating the Lipid Profile Difference and Efficacy of a Combined Therapy Including Tenofovir, Emtricitabine + Atazanavir / r or NVP in Naive HIV - 1 Infected Patients.